Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Great Pacific Exports (GPEPL) is an Indian pharmaceutical company specializing in the development and manufacturing of Highly Potent and High Value Active Pharmaceutical Ingredients (APIs), with a core focus on corticosteroids. Established in 1993 and headquartered in Navi Mumbai, the company serves as a preferred supplier and contract manufacturing partner for both Indian and multinational formulation companies. GPEPL's product portfolio includes key APIs such as Betamethasone, Prednisolone, and Mometasone, which are used in various therapeutic applications including anti-inflammatory and dermatological treatments. The company operates robust R&D and process development laboratories to innovate and enhance its product offerings while maintaining high standards of quality and regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Great Pacific.